Top compounds associated with response to TIMELESS


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.19 7e-11
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.22 7e-11
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-09
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.23 2e-09
mRNA CD-437 CTRPv2 pan-cancer AAC 0.2 2e-09
mRNA etoposide CTRPv2 pan-cancer AAC 0.18 2e-09
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.22 2e-09
mRNA PX-12 CTRPv2 pan-cancer AAC 0.18 2e-09
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.19 3e-09
mRNA SN-38 CTRPv2 pan-cancer AAC 0.22 4e-09
Download CSV